Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Tiotropium vs Nebulised Ipratropium in Stable COPD
NCT00335621Phase 4Withdrawn
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tiotropium in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by NHS Greater Glasgow and Clyde. Primary endpoint: Forced Expiratory Volume in 1 second at 12 weeks. Planned start Jun 2006; status: withdrawn.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00335621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335621.